Department of Immunology and Oncology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Cientificas, 28049 Madrid, Spain.
Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13736-41. doi: 10.1073/pnas.1001399107. Epub 2010 Jul 14.
The longevity-promoting NAD+-dependent class III histone deacetylase Sirtuin 1 (SIRT1) is involved in stem cell function by controlling cell fate decision and/or by regulating the p53-dependent expression of NANOG. We show that SIRT1 is down-regulated precisely during human embryonic stem cell differentiation at both mRNA and protein levels and that the decrease in Sirt1 mRNA is mediated by a molecular pathway that involves the RNA-binding protein HuR and the arginine methyltransferase coactivator-associated arginine methyltransferase 1 (CARM1). SIRT1 down-regulation leads to reactivation of key developmental genes such as the neuroretinal morphogenesis effectors DLL4, TBX3, and PAX6, which are epigenetically repressed by this histone deacetylase in pluripotent human embryonic stem cells. Our results indicate that SIRT1 is regulated during stem cell differentiation in the context of a yet-unknown epigenetic pathway that controls specific developmental genes in embryonic stem cells.
长寿促进 NAD+ 依赖的 III 类组蛋白去乙酰化酶 Sirtuin 1(SIRT1)通过控制细胞命运决定和/或调节 p53 依赖性 NANOG 的表达来参与干细胞功能。我们表明,SIRT1 在人胚胎干细胞分化过程中在 mRNA 和蛋白质水平上都被精确地下调,并且 Sirt1 mRNA 的减少是由涉及 RNA 结合蛋白 HuR 和精氨酸甲基转移酶共激活因子相关的精氨酸甲基转移酶 1(CARM1)的分子途径介导的。SIRT1 的下调导致关键发育基因的重新激活,如神经视网膜形态发生效应物 DLL4、TBX3 和 PAX6,这些基因在多能性人胚胎干细胞中被这种组蛋白去乙酰化酶表观遗传抑制。我们的结果表明,SIRT1 在干细胞分化过程中受到调控,其涉及胚胎干细胞中特定发育基因的未知表观遗传途径。